Clinical Trials Logo

Tolerance clinical trials

View clinical trials related to Tolerance.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06232460 Not yet recruiting - Tolerance Clinical Trials

An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide

Start date: January 29, 2024
Phase: N/A
Study type: Interventional

This study evaluates the safety and tolerability of three different doses (5 g, 10 g and 20 g) of a collagen powder in healthy adults over a 12-week period.

NCT ID: NCT06189170 Not yet recruiting - Safety Issues Clinical Trials

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

Start date: June 10, 2024
Phase: Early Phase 1
Study type: Interventional

This study will explore the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of KP405 as a potential new treatment for Parkinson's disease.

NCT ID: NCT05960045 Not yet recruiting - Tolerance Clinical Trials

Testing Tolerance in Cow Milk Protein Allergy Patients: Milk Ladder or Direct Milk Administration?

Start date: August 20, 2023
Phase: N/A
Study type: Interventional

Majority of children outgrow their allergies, however there are two different methods to re-introduce milk products in the infant diet either direct milk intake in escalating doses or milk ladder, starting with baked milk products instead of pure milk. This study aims to compare rate of tolerance after milk reintroduction among patient with cow milk protein allergy (CMPA) diagnosed by elimination re-challenge test after six months of elimination diet by milk ladder versus direct milk intake.

NCT ID: NCT05644717 Not yet recruiting - Liver Fibrosis Clinical Trials

Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD

Ertu-NASH
Start date: March 1, 2023
Phase: Phase 4
Study type: Interventional

Open-label, prospective, single-arm, multicenter study to determine effects of Ertugliflozin on liver fat, liver fibrosis & glycemic control in subjects with Type 2 Diabetes Mellitus (T2DM) with Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic Steatohepatitis (NASH)

NCT ID: NCT05428748 Not yet recruiting - Tolerance Clinical Trials

Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

This clinical trial design aims to evaluate the safety and tolerability of a novel hydration drink in health volunteers.

NCT ID: NCT04300699 Not yet recruiting - Quality of Life Clinical Trials

Feasibility of Frailty Assessment and Implementation of Interventions in Women Over 70 With Epithelial Ovarian Cancer

FAIR-O
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Ovarian cancer is frequently diagnosed in older women, with over half of all new diagnoses being in women over 65 years. Current treatment options are based on the results of clinical trials that often do not include older, less fit patients in whom treatments may be less well tolerated. Further, in older patients the impact of complex medical and social issues is not known. The UK lags behind Europe and the United States in the development of research programs dedicated to improving outcomes for older patients. More research focus is urgently required to improve the assessment and management of older women with ovarian cancer to improve survival outcomes, quality of life and functional independence. Current treatment decisions are made predominantly on age and fitness. However, it has been shown that undertaking a holistic, geriatric assessment of older patients can highlight important issues that would not necessarily be identified in a routine oncology appointment. In this study, we propose to ask oncology teams to undertake a geriatric assessment and specifically address issues that may arise as a result of this. The assessment comprises 8 simple non-invasive assessments that can be performed in the out-patient setting. This approach could result in an important change in clinical practice leading to more holistic assessment of older cancer patients and better address their specific needs and manage their cancer treatment. The long-term goal is to show that pro-actively managing potential issues at the beginning of treatment allows patients to tolerate treatment and maintain their functional independence, leading to improved quality of life.

NCT ID: NCT03163212 Not yet recruiting - Safety Issues Clinical Trials

Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants

Start date: June 2017
Phase: Early Phase 1
Study type: Interventional

This study will examine the safety and tolerability of supplementation with bovine lactoferrin with fructo-oligosaccharide a simple sugar in very low birth weight infants. Lactoferrin is a major whey protein in mother's milk and plays a role in promoting a mature and healthy gut. It also has antimicrobial and immunomodulation activities.